Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
NCT00835055 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-04-05
Summary
The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
Conditions
Sponsors & Collaborators
-
St. Claraspital AG
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2019-04-01
- Completion
- 2019-04-01
Countries
- Switzerland
Study Locations
More Related Trials
-
Study of the Predictive and Prognostic Role of Pharmacogenetic and Radiogenic Variants on the Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer
NCT06616870 ·Status: NOT_YET_RECRUITING
-
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
NCT03731130 ·Status: RECRUITING
-
Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer
NCT01716949 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer.
NCT01814969 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiological Markers in Locally Advanced Rectal Cancer
NCT06843655 ·Status: NOT_YET_RECRUITING
-
Anal Cancer Radiotherapy Study
NCT01937780 ·Status: ACTIVE_NOT_RECRUITING
-
Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission
NCT05964530 ·Status: RECRUITING ·Phase: NA
-
The Predictive Value of Cytokines on Response to Preoperative Chemoradiotherapy in Patients With Rectal Cancer
NCT02077296 ·Status: COMPLETED
-
Validation of a Predictive Model After Complete Response in Rectal Cancer
NCT00969657 ·Status: COMPLETED
-
Observational Study on the Patients With Rectal Cancer
NCT02312284 ·Status: COMPLETED
-
Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer
NCT01443377 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
NCT00414232 ·Status: COMPLETED
-
Study of Short Course Radiation Therapy for Elderly Patients With Rectal Cancer
NCT04139967 ·Status: TERMINATED ·Phase: NA
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy
NCT02052921 ·Status: TERMINATED ·Phase: NA
-
Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy
NCT02369939 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2
-
Prediction of Response to Neoadjuvant Therapy in Rectal Cancer
NCT02439086 ·Status: UNKNOWN ·Phase: NA
-
Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer
NCT01648894 ·Status: COMPLETED ·Phase: PHASE3
-
Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer
NCT04095468 ·Status: RECRUITING
-
Preoperative Chemoradiation With Capecitabine and Cetuximab
NCT00297128 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Rectal Cancer Treatment Response Using PET/MRI
NCT02233595 ·Status: TERMINATED
-
Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers
NCT00808379 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer
NCT00122291 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal Cancer
NCT00931203 ·Status: COMPLETED ·Phase: PHASE2